Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.

@article{Labarga2014ChangesIL,
  title={Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.},
  author={Pablo Labarga and Jos{\'e} Vicente Fern{\'a}ndez-Montero and Pablo Barreiro and Javier Ara Pinilla and Eugenia Vispo and Carmen de Mendoza and Zulema Plaza and Vicente Soriano},
  journal={Journal of viral hepatitis},
  year={2014},
  volume={21 7},
  pages={475-9}
}
There is scarce information about the impact of antiviral treatment on subsequent progression of liver fibrosis in HIV-infected patients with chronic hepatitis C who experience different outcomes following peginterferon-ribavirin therapy. We conducted a retrospective study of a cohort of HIV/HCV-coinfected patients with longitudinal assessment of liver fibrosis using elastometry. Patients were split out into four groups according to the prior peginterferon-ribavirin response: sustained… CONTINUE READING